For large colonic adenomas, endoscopic submucosal dissection (ESD) reduces the local recurrence rate compared with endoscopic mucosal resection (EMR), but the adverse event rate is higher. In ...
Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "Endoscopic Submucosal Dissection Market - A Global and Regional Analysis: Focus on Indication, Product, End user, Country, and Region - Analysis and ...
Prophylactic defect closure after endoscopic submucosal dissection (ESD) of the colon was associated with lower rates of delayed bleeding and post-procedure hospital admission, with the benefit more ...
Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer. A multicenter phase 2 trial of ramucirumab plus FOLFIRI as ...
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic CRC: Analysis of patients treated within the PanaMa trial (AIO KRK 0212). Panitumumab ...
Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...
ESD is performed with a thin, flexible endoscope inserted through the mouth or rectum. Using miniature tools, clinicians inject fluid to lift a precancerous or early cancer lesion from surrounding ...
OAK BROOK, Ill. – January 27, 2009 – A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a ...
Background Oncological principles favour en bloc R0 excision for curative endoscopic resection. In Barrett’s neoplasia, ...
New data confirms younger and younger Americans are being diagnosed with colon cancer. The good news is new technology can remove early-stage cancers without surgery - but to catch it early, doctors ...
A research team at Tohoku University, in collaboration with Denka Company Limited and U-A Corporation, has developed a ...